{"entity":{"id":"nct06514651","kind":"trial","name":"MAQ-001 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of MAQ-001 run by MabQuest SA, now recruiting.","summary":"MAQ-001 in Patients With Advanced Solid Tumors is a phase 1 interventional study registered as NCT06514651 by MabQuest SA, with 30 participants planned, started 2024-06-06. Conditions recorded: Advanced Solid Tumor. Interventions recorded: MAQ-001 and Ipilimumab.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT06514651","url":"https://clinicaltrials.gov/study/NCT06514651"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["maq-001"],"companies":["mabquest"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06514651","phase":"1","setting":"A Phase IA/IB Study to Investigate the Safety, Tolerability, and Pharmacokinetic Characteristics of Intravenous (IV) MAQ-001 as Monotherapy and Combination Immunotherapy in Patients With Advanced Solid Tumors","sponsor":"MabQuest SA","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06514651/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"maq-001","kind":"drug","name":"MAQ-001","route":"/drugs/maq-001/"}],"company":[{"id":"mabquest","kind":"company","name":"MabQuest","route":"/companies/mabquest/"}]}}